Due to COVID-19, the routine treatment for dementia, Cognitive Stimulation Therapy (CST), is currently suspended in multiple countries. Access to treatment is, therefore, paramount. The investigators seek to bridge the current treatment gap with a virtual and individual form of CST, called Virtual Individual Cognitive Stimulation Therapy (V-iCST). This psychosocial intervention was adapted from the key principles of CST and developed within the Medical Research Council (MRC) framework for complex interventions. The investigators aim to evaluate the feasibility and acceptability of V-iCST in a Randomized Controlled Trial. This is a feasibility randomized controlled trial (RCT) for Virtual Individual Cognitive Stimulation Therapy (V-iCST), an evidence-based teletherapy for people with mild to moderate dementia. This psychosocial intervention is adapted from a routine and established dementia treatment, Cognitive Stimulation Therapy, and developed within the Medical Research Council (MRC) framework for complex interventions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Recruitment (feasibility of V-iCST)
Timeframe: Descriptive data will be collected during the study and analysed post-intervention; through study completion, 2 years
Retention rate (feasibility of V-iCST)
Timeframe: Descriptive data will be collected during the study and analyzed post-intervention; at 9-week follow-up
Attendance and retention rate (acceptability of V-iCST)
Timeframe: Descriptive data will be collected during the study and analyzed post-intervention; at 9-week follow-up
Negative of adverse events (acceptability of V-iCST)
Timeframe: Descriptive data will be collected during the study and analyzed post-intervention; through study completion, 2 years
Fidelity (acceptability of V-iCST)
Timeframe: Descriptive data will be collected during the study and analyzed post-intervention; through study completion, 2 years